TTOO T2 Biosystems
- 4.7800
- -0.3600-7.00%
- 4.9700
- +0.1900+3.97%
T2 Biosystems News
T2 Biosystems | S-3: Registration statement for specified transactions by certain issuers
T2 Biosystems | 8-K: Disclosure Information of Public Offering in Compliance With Nasdaq Listing Rule 5550(b)(2)
T2 Biosystems | 8-K: Entry into a Securities Purchase Agreement
T2 Biosystems | RW: Registration Withdrawal Request
T2 Biosystems | 8-K: Current report
T2 Biosystems | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Nathan D. Hukill(69.5%),CR Group L.P.(69.5%), etc.
T2 Biosystems | 4: Statement of changes in beneficial ownership of securities-10% Owner CR Group L.P.
T2 Biosystems | FWP: Filing under Securities Act Rules 163/433 of free writing prospectuses
T2 Biosystems | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Nathan D. Hukill(65.4%),CR Group L.P.(65.4%), etc.
T2 Biosystems | 4: Statement of changes in beneficial ownership of securities-10% Owner CR Group L.P.
T2 Biosystems | 8-K: Amendment and Restatement Certificate of Designation of Preferences, Rights and Limitations of Convertible Preferred Stock
T2 Biosystems | FWP: Filing under Securities Act Rules 163/433 of free writing prospectuses
T2 Biosystems | FWP: Filing under Securities Act Rules 163/433 of free writing prospectuses
T2 Biosystems | S-1/A: General form for registration of securities under the Securities Act of 1933 (Amendment)
T2 Biosystems | 8-K: T2 Biosystems Announces First Quarter 2024 Financial Results
T2 Biosystems | 10-Q: Quarterly report
T2 Biosystems | S-1/A: General form for registration of securities under the Securities Act of 1933 (Amendment)
T2 Biosystems | S-1: General form for registration of securities under the Securities Act of 1933
T2 Biosystems | SC 13D: Statement of acquisition of beneficial ownership by individuals-Nathan D. Hukill(46.68%),CR Group L.P.(46.68%), etc.
T2 Biosystems | 8-K: Agreement of Debt Conversion Into Equity
Analysis
Price Target
No Data
